Food4future Technologiessp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-06-21
Share capital
18 050,00 PLN
Registered address
Gajowa 5, 55-095 Byków, Poland
Electronic delivery address
AE:PL-32166-58497-WGSJU-20

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 931.24kMedianUSD 38.31kAverageUSD 2.31m
Net profit
This companyUSD -82.92kMedianUSD -1.58kAverageUSD -89.61k
Operating costs
This companyUSD 982.07kMedianUSD 56.25kAverageUSD 2.28m
Assets
This companyUSD 2.53mMedianUSD 120.24kAverageUSD 2.72m

Bank accounts

Registered as a VAT taxpayer on 2018-02-24. Active

  • mBank
    05 1140 1140 0000 4290 5200 1006
  • mBank
    10 1140 1140 0000 4290 5200 1013
  • mBank
    16 1140 1140 0000 4290 5200 1002

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

15 public aid cases recorded, with a total value of $4,454,187.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$8,621
Aid for research and development projects: experimental development
$944.0K
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$4,923

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Katarzyna Anna Pala – President of the Management Board
Tomasz Gondek – Vice President of the Management Board
Per Kristian Nordoy – Vice President of the Management Board

Manner of representation

The following persons are authorised to make declarations of will on behalf of the company: 1. in the case of a one-person management board, a member of the management board independently; 2. in the case of a multi-member management board, two members of the management board or one member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Solutio Diagnostics As
37$499.7310.2493%
Tarczyński S.A.
60$810.3716.6205%
Others
264$3,565.6473.1302%

Beneficial owners

Person

Subsidiaries

NameStake
Saomesp. z o.o.
100%

Competitors

Name
COS LabP.S.A.
Syventosp. z o.o.
Zakład Genetyki Sądowejsp. z o.o.
GenxoneS.A.
Vitrotest Europesp. z o.o.
VASA Therapeuticssp. z o.o.
MultiqureS.A.
GenomtecS.A.
Centrum Transferu Technologii Meditransfer Iitdsp. z o.o.
Olenasp. z o.o.

Change history

DateEvent
2025-05-09Address change
2023-06-30Share capital change
2022-08-02Name change
2022-07-29Share capital change
2022-07-29Name change

FAQ

Last updated: 2026-10-07